1. Home
  2. CTNM vs ITRG Comparison

CTNM vs ITRG Comparison

Compare CTNM & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

SELL

Current Price

$9.57

Market Cap

550.7M

Sector

N/A

ML Signal

SELL

Logo Integra Resources Corp.

ITRG

Integra Resources Corp.

SELL

Current Price

$1.74

Market Cap

486.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
CTNM
ITRG
Founded
2009
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
550.7M
486.9M
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
CTNM
ITRG
Price
$9.57
$1.74
Analyst Decision
Buy
Buy
Analyst Count
8
8
Target Price
★ $21.43
$5.13
AVG Volume (30 Days)
596.9K
★ 1.6M
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 0.46
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.03
Revenue Next Year
N/A
$37.21
P/E Ratio
★ N/A
$45.07
Revenue Growth
N/A
★ N/A
52 Week Low
$6.73
$1.77
52 Week High
$17.79
$4.87

Technical Indicators

Market Signals
Indicator
CTNM
ITRG
Relative Strength Index (RSI) 46.25 29.21
Support Level $8.59 N/A
Resistance Level $13.72 $2.96
Average True Range (ATR) 0.77 0.12
MACD 0.23 -0.03
Stochastic Oscillator 42.33 5.75

Price Performance

Historical Comparison
CTNM
ITRG

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: